Injective (INJ) is currently priced at $2.81, reflecting a 24-hour change of -2.34%. The price has fluctuated between a high of $2.88 and a low of $2.78 during this period, indicating a narrow daily range of 0.1%.

Volume over the last 24 hours stands at approximately 31 million, resulting in a volume-to-market cap ratio of 11.05%. The short-term moving averages show mixed signals, with the 8 SMA at $2.80 indicating a slight uptrend, while the longer-term SMAs (55 SMA at $2.86 and 144 SMA at $2.96) show a downtrend, suggesting overall bearish momentum.

The Relative Strength Index (RSI) readings are currently at 41 for both the hourly and 7-day periods, indicating the asset is nearing oversold conditions. The 7-day price change of -4.96%, along with a 14-day change of -9.36% and a 30-day decline of -8.28%, reinforces a downward price trend and investor caution.

Given the substantial drop from its all-time high of $52.62 in March 2024, market sentiment is bearish, and the ongoing price action supports this outlook. The lack of significant buying pressure, as evidenced by the RSI and moving averages, suggests limited short-term upside potential.

In conclusion, the technical indicators and price movements indicate a challenging environment for Injective (INJ). A Sell rating is recommended at this time, as the asset is showing signs of continued bearish pressure with no immediate catalysts for a reversal.